Abstrak
Nowadays, the pattern of morbidity and mortality in Indonesia has shifted from infectious to degenerative diseases, such as cardio-and cerebrovascular diseases and cancer. Almost all risk factors for those diseases could induce hypoxic condition, indicating the involvement of hypoxia in pathogenesis of the degenerative diseases. 1 Hypoxia is a pathological condition in which the body as a whole or region of the body is deprived of adequate oxygen supply. This condition threatens life of cells or organisms. The ability to maintain oxygen homeostasis is essential for the survival of all aerobic species. Oxygen homeostasis mechanisms can occur at systemic level and cellular level, such as by oxygen sensing. At systemic level, low oxygen could stimulate heart rate, peripheral vasodilatation and hyperventilation, whereas at cellular level, anaerobic metabolic pathways would be activated. 2, 3 One of the cellular oxygen sensing reactions in hypoxia is the increased level of hypoxia-inducible factor-1α (HIF-1). HIF-1α is a ubiquitous intracellular protein that is degraded by prolyl hydroxylase right after its biosynthesis in normoxic condition. Stabilized HIF-1α joins HIF-1β to form HIF-1 transcription factor which interacts with HRE (HIF-1 response element) and regulates the transcription of essential genes for the adaptation responses to hypoxia. [4] [5] [6] Hypoxia results in an increased generation of reactive oxygen species (ROS), such as superoxide anion radical (O 2
•-) and hydrogen peroxide (H 2 O 2 ) in mitochondria. Free radicals are molecules that have at least one unpaired electron and thus are very reactive. The term ROS also includes reactive oxygen species which are chemically not radicals, e.g., hydrogen peroxide. Under hypoxic condition, the consumption of oxygen at cytochrome c oxidase level (complex IV of the mitochondrial electron transport chain) is lower than under normoxic conditions and electrons accumulate at the preceding complex III. Such an accumulation leads to an increased generation of ROS at complex III 7 or on the transport between the two complexes by cytochrome C. In hypoxia, ROS also participate in signal transduction pathways inducing the stabilization of HIF-1α. Moreover, pro-oxidant treatment in normoxic cells can activate genes that induce hypoxia. 3, 8 Superoxide dismutase (SOD) is one of the antioxidant enzymes that could protect cells from oxidative damage. This enzyme converts very reactive superoxide anion radicals (O 2
•-) to less reactive hydrogen peroxide (H 2 O 2 ). Among the three isoforms of SOD, manganese superoxide dismutase (MnSOD) is the major antioxidant enzyme in mitochondria that scavenges superoxide radicals generated by the electron transport chain in mitochondria.
7 Decreasing the MnSOD level could elevate ROS levels in mitochondria and lead to oxidative stress including oxidative the damage of biomacromolecules, such as proteins, lipids and DNA. 9 Many studies have explained the important role of MnSOD in the prevention of oxidative stress. 10, 11 However, little is known about the expression of MnSOD during systemic hypoxic conditions, particularly in the essential tissues, such as brain, heart and blood. In the present study, mRNA expression and specifi c activity of MnSOD were analyzed. The information about 
Systemic hypoxia induction
Twenty-fi ve male Sprague Dawley rats (6-8 weeks old; body weight 150-200 g at entry into protocol) were randomly divided into 5 groups (n = 5 per group). Rats were subjected to systemic hypoxia by placing them into a normobaric hypoxic chamber treated with 8-10% of O 2 for 0 (control rats without hypoxia), 1, 7, 14 and 21 days, respectively. The hypoxic chamber (kindly provided by Dr. F. Ferdinal) was designed as previously described by Corno et al. 12 All rats had free access to water and standard rat chow. Water and food consumption was assessed every 2 days.
Isolation of total RNA and protein
After hypoxic treatment, rats were sacrifi ced with ether anaesthesia. Rat blood was immediately collected from the heart for blood gas analysis. Subsequently, brain and heart tissues were rapidly excised. Samples from blood, heart and brain were used for the analysis of mRNA expression and specifi c activity of MnSOD. All excision procedures were executed in the hypoxic chamber.
Whole blood (200 μl) was added into 600 μl of Red Blood Cell Lysis Solution® (Promega). The mixture was incubated for 10 minutes at room temperature and centrifuged at 16000 rpm for 20 seconds. The white pellet containing leucocytes was collected and kept at -80 0 C before use. Total RNA was extracted from leucocytes and tissue samples (100 mg) using Tripure RNA Isolation Kit® (Roche) and was kept at -80 0 C before use. The isolation of total protein from leucocytes and tissue samples was performed as previously described by Hardiany et al.
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Analysis of MnSOD mRNA relative expression using Real Time RT-PCR
Total RNA (~300 ng) was amplifi ed using iScript One Step RT-PCR Kit with SYBR Green® (BioRad). cDNA synthesis and PCR amplifi cation were carried out in the same tube.
Reaction protocol was as follows: cDNA synthesis for 10 minutes at 50 o C; inactivation of reverse transcriptase for 5 minutes at 95°C; PCR cycles (40 cycles) for 10 seconds at 95°C, 30 seconds at 59°C (after optimalization), 30 seconds at 72°C; melting curve analysis for 1 minute at 95°C, 1 minute at 55°C; 10 seconds at 55°C (80 cycles increasing 0.5°C each cycle). Primers were designed according to NCBI gene bank data: NM_017051 (for MnSOD) and NM_031144 (for β-actin as a reference gene) using Primer3 program & Primer Analysis software. Primer sequences used to generate cDNA for MnSOD (178 bp) are: 5'-AACGTCACCGAGGAGAAGTA -3' (forward); 5'-TGATAGCCTCCAGCAACTCT -3' (reverse) and those used to generate cDNA for β-actin (174 bp) are: 5'-CACTGGCATTGTGATGGACT -3' (forward); 5'-CTCTCAGCTGTGGTGGTGAA -3' (reverse). Amplifi cation procedures for the β-actin gene were the same as for the MnSOD gene. Aqua bidest was used as a negative control (NTC) to reduce false positive results. The level of mRNA expression of treated groups was relatively determined using PfaffI formula and normalized to the control group (as a calibrator with expression level of 1).
Analysis of MnSOD specifi c activity
SOD activity was biochemically determined using xanthine oxidase inhibition assay, as previously described. 13 To inhibit the Cu/ZnSOD, prior to addition of xanthine oxidase, natrium cyanide (5 mM) was fi rst added into each sample and incubated for 5 minutes in room temperature. Kinetic of enzyme activity was measured using spectrophotometer at 505 nm after 30 seconds and 3 minutes and calculated as a percentage inhibition of the samples plotted to the standard curve. The specifi c activity of MnSOD enzyme was calculated as enzyme activity (in Unit) per mg protein. Protein concentration was measured using spectrophotometer at 280 nm and plotted to the BSA (Bovine Serum Albumin) standard curve. Specifi c activity of MnSOD in rat blood, heart and brain are expressed as Unit/gram protein, and compared by using t-test.
RESULTS
Analysis of MnSOD mRNA expression using Real Time RT-PCR was fi rst optimized for the primers' specifi city. As shown in Figure 1 , there was merely a single peak in the melting curve and a single band in the electrophoresis of cDNA product of MnSOD as well as β-actin. This indicates that the primers designed in this study for both genes could generate the specifi c cDNA products and there were no primer dimers present. Figure 2 shows that MnSOD mRNA relative expression in rat blood and heart was decreased during early induced systemic hypoxia (day 1) and continuously increased after 7 days of systemic hypoxia. Compared to this result, the relative expression of MnSOD mRNA in rat brain was increased from day 1 of induced systemic hypoxia and reached its maximum level at day 7.
The result of MnSOD specifi c activity during early systemic hypoxia was similar to the result of mRNA expression. Figure  3 demonstrates that MnSOD specifi c activity in rat blood and heart during early systemic hypoxia was signifi cantly (t-test; p < .05) decreased on day 1 and subsequently increased afterwards, whereas this activity in rat brain was signifi cantly increased from day 1 up to day 14 of systemic hypoxia (t-test; p < .01). However, under very late hypoxic condition (day 21) the result of MnSOD specifi c activity in blood, heart and brain was obviously different compared to mRNA expression, since MnSOD activity was decreased, indeed signifi cantly lower in blood and heart as compared to the control group (t-test; p < .01).
In fi gure 4, we analyzed the Pearson correlation between mRNA expression and specifi c activity of MnSOD in these three tissues of systemic hypoxia-induced rats (days 0-21), which have been normalized to the control. The analysis resulted in a negative correlation in rat blood (r = -0.250) and heart (r = -0.618). In contrast to that, a moderate positive correlation was shown in brain (r = 0.528). Nevertheless, when we analyzed this correlation in blood and heart of systemic hypoxiainduced rats (days 0-14), we also found a positive correlation in blood (r = 0.616), as well as in heart (r = 0.943). This deviation is due to a drastical decrease of the MnSOD specifi c activity under very late systemic hypoxic condition (day 21), although the expression of MnSOD mRNA remained increased.
To analyze the correlation of MnSOD mRNA expression and specifi c activity in heart or brain compared to that in blood, we performed Pearson statistical correlation analysis. We found that there was a positive correlation between the MnSOD mRNA expression in heart and blood (r = 0.6051), as well as in brain and blood (r = 0.5509). The same analysis performed for the MnSOD specifi c activity resulted in a signifi cant strong correlation between heart and blood (r = 0.9009), but a weak correlation in brain and blood (r = 0.3167).
DISCUSSION
In this study, exposure to normobaric systemic hypoxia induced profound changes in blood oxygen transport characteristics such as decreased p a O 2 , haematocrit and haemoglobin values (data not shown). These changes are a well-known consequence of increased hypoxiainduced erythropoietin production. Our parallel study using the same animal model and tissue samples reported that the expression of HIF-1α as the oxygen sensor in hypoxic condition has distinct capacity and sensitivity in blood, heart and brain due to the need of oxygen homeostasis in these particular tissues. 15 Other previous studies in our group also demonstrated that induction of systemic hypoxia increased the expression of HIF-1α in rat liver tissue during the early phase and subsequently decreased HIF-1α expression as hypoxia continued. 16 The analysis of MnSOD mRNA expression in rat blood and heart during induced systemic hypoxia resulted in a similar pattern, indicating that the synthesis of MnSOD in both tissues is similarly regulated. Moreover, this fi nding is supported by the result of MnSOD specifi c activity, which demonstrates that both values exert signifi cantly lower levels in the early phase of systemic hypoxia as compared to the control group. This indicates that under early systemic hypoxia (day 1), MnSOD mRNA synthesis in blood and heart was down-regulated, which might be due to the sudden accumulation of ROS. Thus, the cells could not provide enough MnSOD through gene expression to eliminate ROS. Signal transduction pathway for this response is not yet understood and still under our investigation. Surprisingly, this phenomenon was not found in the brain. Obviously, the brain has a different pattern of MnSOD specifi c activity compared to blood and heart during the time course of hypoxic induction, particularly in the early stage. We assume that the MnSOD adaptation response in brain in the early phase of systemic hypoxia is more sensitive than in blood and heart suggesting that the brain is less affected by induced systemic hypoxia. Moreover, in contrast to other tissues, brain has an auto-regulation mechanism under low oxygen level condition, such as vasodilatation in order to achieve better oxygen supply. 17 This mechanism leads to less severe hypoxia and less ROS production than in other tissues. Consequently, also MnSOD response in brainalthough more sensitive to hypoxia -was generally less expressed than in heart and blood.
The MnSOD response in brain during induced systemic hypoxia correlates well with the HIF-1α adaptation response. As reported in our parallel study, the increase of HIF-1α expression in brain was not as obvious as compared to that in heart and blood. This might be due to the low level of ROS in brain. 8, 15 Taking these results together, we can suggest that the adaptation response to systemic hypoxia in brain is differs from that in heart and blood.
The increase of MnSOD activity seems to be one of the cells' adaptive responses -instead of HIF-1α stabilization -through antioxidant protection against the accumulation of ROS during induced systemic hypoxia. Indeed, it has been reported that MnSOD could modulate HIF-1α induction through superoxide anion radical. 18, 19 This data was supported by another study demonstrating that overstimulation of the expression of catalase and gluthatione peroxidise could decrease HIF-1α stabilization during hypoxia.
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One should also note that MnSOD activity was decreased in blood, heart as well as brain under very late hypoxic condition (day 21). This indicates that the capacity of MnSOD to eliminate accumulated ROS had become saturated (as found in brain) or in fact reduced to lower levels than in normoxia (as found in blood and heart). Previous study has reported that hypoxia could stimulate ROS production in the mitochondria and regulate transcription and post-transcription responses against low level of oxygen. 21 Russel et al. reported that MnSOD activity in the lungs of mice was signifi cantly decreased under hypoxic condition, whereas its mRNA expression was not different from control. 22 Furthermore, under very late hypoxic condition ATP production is reduced leading to the inhibition of protein translation even though mRNA expression increases. The inhibition of protein translation during hypoxia appears to be an effort of cells to reduce energy consumption in order to maintain the energy balance. However, this inhibition was shown to be still reversible.
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In hypoxic condition, MnSOD gene expression might be regulated by redox-sensitive transcription factors, such as SP-1, AP-1 and NF-κB. 3 Ohman et al. have demonstrated that the increase of ROS could activate NF-κB, hence induce the transcription of regulated genes including MnSOD gene. 24 This data confi rms our suggestion that the MnSOD gene expression during hypoxic condition is regulated through the increase of ROS.
It should also be considered that the levels of MnSOD specifi c activity in each tissue were distinct although measured under the same condition. This indicates that sensitivity and effi ciency of the antioxidant response in brain, heart and blood cells vary depending on the extent of ROS accumulation. Analysis of correlation between the level of mRNA expression and specifi c activity of MnSOD during days 0-21 of systemic hypoxia resulted in an obvious deviation from the correlation during days 0-14. Changes in mRNA expression were parallel to the changes in specifi c activity of MnSOD in blood, heart and brain during days 0-14 of systemic hypoxia. However, at day 21 MnSOD specifi c activity decreased drastically, even though mRNA expression increased considerably. This might be due to the production of massive amounts of ROS as an impact of induced systemic hypoxia at the very late stage. The increase of mRNA expression is not suffi cient to eliminate the oxidative stress. This suggestion is supported by the decrease of enzyme specifi c activity, indicating that the capacity of MnSOD for eliminating the accumulated ROS has been saturated.
The positive correlation of MnSOD mRNA expression and specifi c activity between heart and blood of systemic hypoxic rats is more signifi cant and stronger than the correlation between brain and blood. This indicates that the effect of systemic hypoxia on MnSOD expression in blood could better describe its effect in heart than in brain cells. Therefore, we suggest that determination of MnSOD expression (mRNA and level of specifi c activity) in blood can be used as a biomarker of its expression in heart. This fi nding would obviously bring more benefi t for clinical application, since the determination of MnSOD expression in human heart under hypoxic condition is still not applicable.
From our results, we conclude that the expression of MnSOD in different tissues as well as at different stages (early and late) of induced systemic hypoxia in rats is distinctly regulated. Brain tissue appears to survive better during induced systemic hypoxia than heart and blood cells, due to earlier antioxidant response through MnSOD activity. Moreover, the determination of MnSOD expression in blood could be used to describe its expression in heart. Further studies are required to elaborate the MnSOD specifi c activity in other cells during induced systemic hypoxia, as well as to analyze the correlation between MnSOD expression and apoptosis.
